Insulet Showcases Omnipod Innovations at American Diabetes Association Scientific Sessions
Insulet Corporation, a leader in tubeless insulin pump technology, is presenting new data and innovations at the American Diabetes Association's 86th Scientific Sessions. The company is highlighting advancements in its Omnipod product line, including a next-generation algorithm designed to improve diabetes management by reducing user effort and enhancing clinical outcomes. Insulet's presentations focus on patient-centered design and the performance of its Automated Insulin Delivery systems, which aim to improve time in range and reduce disease burden for individuals with type 1 and type 2 diabetes. 
